Protein associated with aggressive breast cancer.

Dr. Yan Chen (left) and Dr. Weibo Luo (right) discovered that the protein ZMYND8 may be a useful biomarker to indicate breast cancer that will spread.

DALLAS – April 18, 2018 – Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies.

High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients, said Dr. Weibo Luo, Assistant Professor of Pathology and Pharmacology, and with the Harold C. Simmons Comprehensive Cancer Center.

See the full:
News Release interview with Dr. Weibo Luo 
The Journal of Clinical Investigation Article